Free Appendix - District Court of California - California

Case 4:07-cv-04972-CW

Document 21

Filed 03/07/2008

Page 1 of 2

1 MICHAEL L. CHARLSON (Bar No. 122125) 2 ALEXANDER M.R. LYON (Bar No. 211274) 3 275 Middlefield Road
HELLER EHRMAN LLP Menlo Park, California 94025-3506 Facsimile: (650) 324-0638 LAURENCE A. WEISS (Bar No. 164638)

4 Telephone: (650) 324-7000

5 [email protected] 6 [email protected] 7 Attorneys for Defendants
THRESHOLD PHARMACEUTICALS, INC., and JANET I. SWEARSON [email protected]

8 HAROLD E. "BARRY" SELICK 9 10 11 12

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA OAKLAND DIVISION JERRY TWINDE, On Behalf of Himself and All ) ) ) Plaintiff, ) ) v. ) ) THRESHOLD PHARMACEUTICALS, INC., ) HAROLD E. "BARRY" SELICK and JANET I. ) SWEARSON ) ) Defendants. ) __________________________________________ ) RAYNOLD L. GILBERT, On Behalf of Himself ) and All Others Similarly Situated, ) ) Plaintiff, ) ) v. ) ) THRESHOLD PHARMACEUTICALS, INC., ) HAROLD E. "BARRY" SELICK and JANET I. ) SWEARSON ) ) Defendants. ) Case No.: 4:07-CV-04972-CW CLASS ACTION APPENDIX OF UNPUBLISHED AUTHORITIES CITED IN DEFENDANTS' MEMORANDUM OF POINTS AND AUTHORITIES IN SUPPORT OF THEIR MOTION TO DISMISS PLAINTIFFS' CONSOLIDATED AMENDED COMPLAINT FOR VIOLATION OF THE FEDERAL SECURITIES LAWS Hearing Date: Hearing Time: Place: Judge: June 12, 2008 2:00 p.m. Courtroom 2, 4th Floor Hon. Claudia Wilken

13 Others Similarly Situated, 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

APPENDIX OF UNPUBLISHED AUTHORITIES CITED IN DEFENDANTS' MOTION TO DISMISS CASE NO. 4:07-CV-04972-CW

Case 4:07-cv-04972-CW

Document 21

Filed 03/07/2008

Page 2 of 2

1 2 3 4 5 6 7

INDEX OF CASES TAB

Collagenex Pharm., Inc. v. Thompson, 2003 U.S. Dist. LEXIS 12523 (D.D.C. 2003).............................................................. 1 Heywood v. Cell Therapeutics, Inc., 2006 U.S. Dist. LEXIS 28684 (W.D. Wash. 2006) ..................................................... 2

8 In re Bayer AG Sec. Litig., 2004 U.S. Dist. LEXIS 19593 (S.D.N.Y. 2004) .......................................................... 3 9 10 In re DNAP Sec. Litig., 2000 U.S. Dist. LEXIS 13482 (N.D. Cal. 2000) .......................................................... 4 11 12 In re ESS Tech., Sec. Litig., 2004 U.S. Dist. LEXIS 27203 (N.D. Cal. 2004).......................................... .5 13 In re Impax Labs, Inc. Sec. Litig., 14 2007 U.S. Dist. LEXIS 52356 (N.D. Cal. 2007)............................................6 15 In re Intrabiotics Pharms., Inc., 16 2006 U.S. Dist. LEXIS 56427 (N.D. Cal. 2006)............................................7 17 In re NextCard, Inc. Sec. Litig., 2006 U.S. Dist. LEXIS 16156 (N.D. Cal. 2006) ......................................................... 8 18 19 In re SciClone Pharms. Sec. Litig., 1995 U.S. Dist. LEXIS 22054 (N.D. Cal. 1995) .......................................................... 9 20 21 Noble Asset Mgmt. v. Allos Therapeutics, Inc., 2005 U.S. Dist. LEXIS 24452 (D. Col. 2005)............................................................ 10 22 Oppenheim Pramerica Asset Mgt. S.A.R.L. v. Encysive Pharm., Inc., 23 2007 U.S. Dist. LEXIS 69121 (S.D. Tex. 2007) ....................................................... 11 24 SEC v. Todd, 2006 U.S. Dist. LEXIS 41182 (S.D. Cal. 2006)......................................................... 12 25 26 Shuster v. Symmetricom, Inc., 1997 U.S. Dist. LEXIS 14007 (N.D. Cal. 1997) ........................................................ 13 27 28 1
APPENDIX OF UNPUBLISHED AUTHORITIES CITED IN DEFENDANTS' MOTION TO DISMISS CASE NO. 4:07-CV-04972-CW